Laboratorija za molekularnu hematologiju - publikacije

Laboratorija za molekularnu hematologiju - publikacije

Djordjevic M, Klaassen K, Sarajlija A, Tosic N, Zukic B, Kecman B, Ugrin M, Spasovski V, Pavlovic S, Stojiljkovic M. Molecular genetics and genotype based estimation of BH4-responsiveness in Serbian PKU patients: spotlight on phenotypic implications of p.L48S. (DOI 10.1007/8904_2012_178), J Inherit Metab Dis 2013: 36: 163.

Karan-Djurasevic T, Palibrk V, Zukic B, Spasovski V, Glumac I, Colovic M, Colovic N, Jurisic V, Scorilas A, Pavlovic S, Tosic N. Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers. Med Oncol 2013: 30(1):405.

Stojiljkovic M, Fazlagic A, Krivokapic-Dokmanovic L, Nikcevic G, Patrinos GP, Pavlovic S, Zukic B. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy. Hum Genomics. 2012: 6(1):19.

Spasovski V, Tosic N, Nikcevic G, Stojiljkovic M, Zukic B, Radmilovic M, Karan – Djurasevic T, Srzentic S, Colovic M, Pavlovic S. The influence of novel transcriptional regulatory element in intron 14 on expression of Janus kinase 2 gene in myeloproliferative neoplasms. J Appl Genet 2012: 54(1):21-6.

Radmilovic M, Zukic B, Stojiljkovic M, Bartsakoulia M, Stankovic B, Kotur N, Dokmanovic L, Georgitsi M, Patrinos G, Pavlovic S. Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin. Annals of Hematology 2012: 92(1):53-8.

Colovic N, Tomin D, Vidovic A, Tosic N, Atkinson HD, Colovic MD. Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia. Med Oncol. 2012 Mar;29(1):260-2.

Milosevic JD, Puda A, Malcovati L, Berg T, Hofbauer M, Stukalov A, Klampfl T, Harutyunyan AS, Gisslinger H, Gisslinger B, Burjanivova T, Rumi E, Pietra D, Elena C, Vannucchi AM, Doubek M, Dvorakova D, Robesova B, Wieser R, Koller E, Suvajdzic N, Tomin D, Tosic N, Colinge J, Racil Z, Steurer M, Pavlovic S, Cazzola M, Kralovics R. Clinical significance of genetic aberrations in secondary acute myeloid leukemia. Am J Hematol. 2012: 87(11):1010-6.

Thomadaki H, Floros KV, Pavlovic S, Tosic N, Gourgiotis D, Colovic M, Scorilas A. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clin Biochem. 2012: 45(16-17):1362-7.

Kuzmanovic M, Tosic N, Colovic N, Karan-Djurasevic T, Spasovski V, Radmilovic M, Nikcevic G, Suvajdzic-Vukovic N, Tomin D, Vidovic A, Virijevic M, Pavlovic S, Colovic M. Prognostic Impact of NPM1 Mutations in Serbian Adult Patients with Acute Myeloid Leukemia. Acta Haematol. 2012: 128(4): 203-212.

Karan-Djurasevic T, Palibrk V, Kostic T, Spasovski V, Nikcevic G, Srzentic S, Colovic M, Colovic N, Vidovic A, Antic D, Mihaljevic B, Pavlovic S, Tosic N. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2012: 12(4): 252-60.

Puda A, Milosevic JD, Berg T, Klampfl T, Harutyunyan AS, Gisslinger B, Rumi E, Pietra D, Malcovati L, Elena C, Doubek M, Steurer M, Tosic N, Pavlovic S, Guglielmelli P, Pieri L, Vannucchi AM, Gisslinger H, Cazzola M, Kralovics R. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. Am J Hematol. 2012: 87(3): 245-50.

Radojkovic M, Tosic N, Colovic N, Ristic S, Pavlovic S, Colovic M. Reversal of FLT3 Mutational Status and Sustained Expression of NPM1 Mutation in Paired Presentation, and Relapse Samples in a Patient with Acute Myeloid Leukemia. Ann Clin Lab Sci. 2012: 42(2):186-90.

Pavlović S, Zukić B, Nikčević G. Pharmacogenomics of Thiopurine S-Methyltransferase: Clinical Applicability of Genetic Variants. In: Clinical Applications of Pharmacogenetics (eds: Sanoudou D), pp. 75-94 (2012). InTech, Rijeka, Croatia.
http://www.intechopen.com/books/clinical-applications-of-pharmacogenetics

Kotur N, Stankovic B, Kassela K, Georgitsi M, Vicha A, Dokmanovic L, Janic D, Krstovski N, Klaassen K, Radmilovic M, Stojiljkovic M, Nikcevic G, Simeonidis A, Sivolapenko G, Pavlovic S, Patrinos GP, Zukic B. Six-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner. Pharmacogenomics 2012: 13(3):283-95.

Tosic N, Pavlovic S. Molecular genetics of acute myeloid leukemia. Global Journal of Biochemistry (in press).

Georgitsi M, Zukic B, Pavlovic S, Patrinos GP. Transcriptional regulation and pharmacogenomics. Pharmacogenomics 2011: 12(5): 655-73.

Stojiljkovic M, Patrinos G, Pavlovic S. Clinical Applicability of Sequence Variations in Genes Related to Drug Metabolism. Curr Drug Metab 2011: 12 (5): 445-454.

Giardine B, Borg J, Higgs D, Peterson K, Philipsen S, Maglott D, Singleton B, Anstee D, Basak AN, Clark B, Costa F, Faustino P, Fedosyuk H, Felice A, Francina A, Galanello R, Gallivan M, Georgitsi M, Gibbons R, Giordano P, Harteveld C, Hoyer J, Jarvis M, Joly P, Kanavakis E, Kollia P, Menzel S, Miller W, Moradkhani K, Old J, Papachatzopoulou A, Papadakis M, Papadopoulos P, Pavlovic S, Perseu L, Radmilovic M, Riemer C, Satta S, Schrijver I, Stojiljkovic M, Thein SL, Traeger-Synodinos J, Tully R, Wada T, Waye J, Wiemann C, Zukic B, Chui D, Wajcman H, Hardison R, Patrinos P. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet 2011: 43(4): 295-301.

Spasovski V, Tosić N, Kostić T, Zukić B, Stojiljković M, Colović M, Pavlović S. The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms. Arch Biol Sci 2010: 62 (2): 223-230.

Spasovski V, Tošić N, Kostić T, Pavlović S, Čolović M. Mutacija JAK2-V617F kod bolesnika s mijeloproliferativnim neoplazijama – veza sa mutacijom FLT3-ITD. Srp Arh Celok Lek 2010: 138 (9-10): 614-618.

Radmilović M, Zukić B, Stanković B, Karan-Djurasević T, Stojiljković M, Spasovski V, Tosić N, Dokmanović L, Janić D, Pavlović S. Thalassemia Syndromes in Serbia: An update. Hemoglobin 2010: 34 (5): 477-485.

Stojiljković M, Zukić B, Tosić N, Karan-Djurasević T, Spasovski V, Nikcević G, Pavlović S. Novel transcriptional regulatory element in the phenylalanine hydroxylase gene intron. Mol Genet Metab 2010: 101 (1): 81-83.

Zukić B, Radmilović M, Stojiljković M, Tošić N, Pourfarzad F, Dokmanović L, Janic D, Čolović N, Philipsen S, Patrinos G, Pavlović S. Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in gene transcription. Pharmacogenomics 2010: 11 (4): 547-557.

Lazić J, Tošić N, Dokmanović L, Krstovski N, Rodic P, Pavlović S, Janic D. Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia. Med Oncol 2010: 27 (2): 449-453.

Krstovski N, Tošić N, Janic D, Dokmanović L, Kuzmanovic M, Spasovski V, Pavlović S. Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experiance and the review of the literature. Med Oncol 2010: 27(3): 640-645.

Pavlović S, Tošić N, Karan-Đurašević T, Spasovski V, Zukić B. Primena molekularnogenetičkih markera u dijagnostici i praćenju hematoloških maligniteta. In: Savremeni pristupi u laboratorijskoj dijagnostici tumorskih markera: iskustvo projekta FP6 HISERBS/ Current trends in tumor marker diagnosis: experience of FP6 HISERBS project (eds: P. Milenković, Lj. Vićovac, S. Pavlović), pp. 143-162 (2009). IMI, IMGGI, INEP, Univerzitet u Beogradu, Beograd, Srbija.

Lazić J, Dokmanović L, Krstovski N, Predojević J, Tošić N, Pavlović S, Janić D. Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia. Srp Arh Celok Lek 2009: 137(7-8): 384-90.

Radojković M, Ristic S, Pavlović S, Čolović M. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis. Leuk Res 2009: 33 (6): e10-12.

Tošić N, Stojiljković M, Čolović N, Čolović M, Pavlović S. Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication: case report and literature review. Cancer Genet Cytogenet 2009: 193: 98-103.

Pavlović S. TPMT gene polymorphisms: on the doorstep of personalized medicine. Indian J Med Res 2009: 129(5): 478-80.

Jurisić V, Pavlović S, Colović N, Djordjevic V, Bunjevacki V, Janković G, Colović M. Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia. J Genet 2009: 88(2): 149-52.

Pavlović S, Stojiljković M. Molecular diagnosis of phenylketonuria: From defective protein to disease-causing gene mutations. JMB 2009: 28(4): 262-267.

Stojiljković M, Perez B, Desviat LR, Aguado C, Ugarte M, Pavlović S. The Missense p.S231F Phenylalanine Hydroxylase Gene Mutation Causes Complete Loss of Enzymatic Activity In Vitro. Protein J 2009: 28: 294.

Jursić V, Terzić T, Pavlović S, Čolović N, Čolović M. Elevated TNF-a and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis. Pathology Research and Practice 2008: 204: 129-32.

Kollia P, Kalamaras A, Chassanidis C, Samara M, Vamvakopoulos NK, Radmilović M, Pavlović S, Papadakis MN, Patrinos GP. Compound heterozygosity for the Cretan type of non-deletional heriditary persistence of fetal hemoglobin and beta-thalassemia or Hb Sabine confirms the functional role of the A gamma -158 C>T mutation in gamma-globin gene transcription. Blood Cells Mol Dis. 2008 Nov-Dec; 41(3):263-4.

Protić MB, Pavlović ST, Bojić DZ, Krstić MN, Radojčić ZA, Tarabar DK, Stevanović AZ, Karan Đurašević TZ, Gođevac MV, Svorcan PV, Dapčević BD, Jojić NZ. CARD15 gene polymorphisms in Serbian patients with Crohn’s disease: genotype-phenotype analysis. Eur J Gastroenterol Hepatol. 2008 Oct; 20(10):978-84.

Jevtović-Stojmenov T, Kocić G, Pavlović D, Macukanović-Golubovac L, Marjanović G, Đorđević V, Tošić N, Pavlović S. Polymorphisms of tumor-necrosis factor.alpha -308 and lymphotoxin-alpha +250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008 Nov; 49(11):2163-9.

Stojiljković M, Stevanović A, Djordjević M, Petrucev B, Tošić N, Karan Djurasevič T, Aveic S, Radmilovic M, Pavlović S. Mutations in the PAH gene: a tool for population genetic study. Arch Biol Sci: 2007: 59 (3): 161-167.

Čolović N, Tošić N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Čolović M, Pavlović S. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Annals of Hematology 2007; 86: 741-747.

Branković-Srecković V, Milic Rasić V, Djordjević V, Kuzmanović M, Pavlović S. Arterial ischemic stroke in a child with beta-thalassemia trait and methylentetrahydrofolate reductase mutation. J Child Neurol 2007: 22(2): 208-210.

Dokmanović L, Urošević J, Janić D, Jovanović N, Petručev B, Tošić N, Pavlović S. Analysis of Thiopurine S-methyltransferase Polymorhism in the Population of Serbia and Montenegro and Mercaptopurine Therapy Tolerance in Childhood Acute Lymphoblastic Leukemia. Ther Drug Monit 2006; 28: 800-806.

Stojiljković M, Jovanović J, Djordjević M, Grkovć S, Cvorkov Drazić M, Petrucev B, Tošić N, Karan Djurasevic T, Stojanov L, Pavlović S. Molecular and phenotypic characteristics of phenylketonuria patients in Serbia and Montenegro. Clin Genet 2006: 70: 151-155.

Čolović M, Jurisić V, Pavlović S, Terzić T, Čolović N. FLT3/D835 mutation and inversion of chromosome 16 in leukemic transformatiom of myelofibrosis. European Journal of Internal Medicine. 2006; 17: 434-435.

 

Ažurirano 28.02.2013